BioSpace News Archive

Policy

EU Says India’s Alchem Is Part of International Drug Price-Fixing Cartel

The European Commission has tagged India-based pharma Alchem as being part of a global cartel that coordinates the pricing of a pharmaceutical ingredient in the antispasmodic drug Buscopan.

June 14, 2024
·
2 min read
·
Tristan Manalac
Drug Development

Genetic Therapies Show Early Promise in Treating Obesity

The plethora of genes involved in obesity presents an intriguing opportunity for both gene silencing and ex vivo gene therapy approaches.

June 14, 2024
·
5 min read
·
Gail Dutton
FDA

BMS’ Augtyro Wins FDA Accelerated Approval for NTRK-Positive Solid Tumors

Based on promising response data from the Phase I/II TRIDENT-1 study, the FDA on Thursday granted Bristol Myers Squibb’s Augtyro accelerated approval for NTRK-positive locally advanced or metastatic solid tumors.

June 14, 2024
·
2 min read
·
Tristan Manalac
Drug Development

With Donanemab on the Cusp of Approval, Proper Alzheimer’s Diagnosis Is Urgent

Accurately diagnosing Alzheimer’s disease pathologies is becoming increasingly important, but the U.S. is facing imaging resource constraints.

June 14, 2024
·
3 min read
·
Greg Slabodkin
Policy

SCOTUS Upholds Access to Abortion Pill, Pharma Industry Applauds Court’s Ruling

The U.S. Supreme Court on Thursday upheld access to the abortion pill mifepristone, unanimously rejecting a challenge by a group of anti-abortion doctors seeking to undo the FDA’s approval of the drug.

June 14, 2024
·
2 min read
·
Tristan Manalac
Deals

Telix Abandons IPO Plans at Last Minute, Cites ‘Current Market Conditions’

Telix abruptly pulled the plug on its initial public offering plans to begin trading Friday on the Nasdaq, saying the company “did not feel that the proposed discounts were aligned with its duty to its existing shareholders.”

June 14, 2024
·
2 min read
·
Tristan Manalac
Drug Development

GLP-1 Global Obesity Market to Reach $111B by 2033, Despite Headwinds: GlobalData

While GLP-1 drugs remain wildly popular and are a highly lucrative sector, data analytics firm GlobalData contends manufacturing and cost will remain overhangs on the obesity market.

June 14, 2024
·
3 min read
·
Tyler Patchen
J.P. Morgan Raises Over $500M for First Biotech Venture Capital Fund

J.P. Morgan’s life sciences venture capital arm on Thursday announced it closed its first biotech fund, targeting companies in cardiometabolic disease, immunology, oncology and genetic medicine.

June 14, 2024
·
2 min read
·
Tyler Patchen
Drug Development

Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201

Cabaletta Bio, Inc. reported positive initial clinical data from each of the first two patients dosed with CABA-201 in the Phase 1/2 RESET-Myositis and RESET-SLE trials.

June 14, 2024
·
13 min read
Genetown

Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patients with Transfusion-dependent Beta Thalassemia, Presented at the European Hematology Association (EHA) Annual Congress

Editas Medicine, Inc., a clinical-stage genome editing company, announced new safety and efficacy data in 7 patients with transfusion-dependent beta thalassemia treated with renizgamglogene autogedtemcel in the Phase 1/2 EdiTHAL clinical trial.

June 14, 2024
·
9 min read